Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report

Author(s): Ahmet Gorgel*, Cem Cankaya, Mehmet Tecellioglu

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 19 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Backgraund and Objective: Anti-Saccharomyces Cerevisiae Antibodies (ASCA) that are considered to reflect immune response against increased intestinal permeability due to mucosal damage are among the serological markers of Crohn’s Disease.

Methods: This microbial seromarker was recently shown to be elevated in several autoimmune disorders such as celiac disease, autoimmune liver diseases, type 1 diabetes, and Graves’ disease. Despite that fact, ASCA seropositivity in Autoimmune Polyglandular Syndrome (APS) has never been reported before.

Results: Herein, we present a 46-year-old woman who has uveitis, autoimmune thyroiditis, and primary ovarian failure.

Conclusion: Based on the coexistence of these diseases, the patient was diagnosed with APS type III. Moreover, ASCA seropositivity was detected although she has no overt intestinal disease.

Keywords: Anti-Saccharomyces Cerevisiae Antibody (ASCA), Autoimmune Polyglandular Syndrome (APS) type III, uveitis, anti-double-stranded DNA, autoimmune hepatititis, antinuclear antibody.

Neufeld, M.; Blizzard, R.M. Polyglandular autoimmune disease. In: Pinchera, A.; Doniach, D.; Fenzi, D.F.; Baschieri, L. (eds.). Autoimmune aspects of endocrine disorders. London, UK, Academic Press,, 1980, 357-365.
Eisenbarth, G.S.; Gottlieb, P.A. Autoimmune polyendocrine syndromes. N. Engl. J. Med., 2004, 350, 2068-2079.
Kasznicki, J.; Drzewoski, J. A case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto’s disease, type 1 diabetes mellitus, and vitiligo. Endokrynol. Pol., 2014, 65(4), 320-323.
McKenzie, H.; Main, J.; Pennington, C.R.; Parratt, D. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut, 1990, 31, 536-538.
Vasiliauskas, E.A.; Kam, L.Y.; Karp, L.C.; Gaiennie, J.; Yang, H.; Targan, S.R. Marker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut, 2000, 47, 487-496.
Arnott, I.D.; Landers, C.J.; Nimmo, E.J.; Drummond, H.E.; Smith, B.K.; Targan, S.R.; Satsangi, J. Sero-reactivity to microbial components in Crohn’s disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol., 2004, 99, 2376-2384.
Viitasalo, L.; Niemi, L.; Ashorn, M.; Ashorn, S.; Braun, J.; Huhtala, H.; Collin, P.; Mäki, M.; Kaukinen, K.; Kurppa, K.; Iltanen, S. Early Microbial Markers of Celiac Disease. J. Clin. Gastroenterol., 2014, 48(7), 620-624.
Fagoonee, S.; De Luca, L.; De Angelis, C.; Castelli, A.; Rizzetto, M.; Pellicano, R. Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol. Dietol., 2009, 55(1), 37-40.
Maillet, J.; Ottaviani, S.; Tubach, F.; Roy, C.; Nicaise-Rolland, P.; Palazzo, E.; Dieudé, P. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: Prevalence and associated phenotype. Joint Bone Spine, 2016, 83(6), 665-668.
Sakly, W.; Mankaï, A.; Sakly, N.; Thabet, Y.; Achour, A.; Ghedira-Besbes, L.; Jeddi, M.; Ghedira, I. Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Endocr. Pathol., 2010, 21(2), 108-114.
Krause, I.; Monselise, Y.; Milo, G.; Weinberger, A. Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet’s disease. Clin. Exp. Rheumatol., 2002, 20(4)(Suppl. 26), 21-24.
Yazıcı, D.; Aydın, S.Z.; Yavuz, D.; Tarçın, O.; Deyneli, O.; Direskeneli, H.; Akalın, S. Anti-Saccaromyces cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease. Endocrine, 2010, 38(2), 194-198.
Salehi-Abari, I. Letter to Editor. 2015 ACR/SLICC Revised Criteria for Diagnosis of Systemic Lupus Erythematosus. Autoimmune Dis. Ther. Approaches, 2015, 2, 114.
North American Menopause Society.. Early menopause guidebook,, 2006. 6th edition. Cleveland, OH, North American Menopause Society .
Kalu, E.; Panay, N. Spontaneous premature ovarian failure: management challenges. Gynecol. Endocrinol., 2008, 24, 273-279.
McLean, M.H.; Dieguez, D., Jr; Miller, L.M.; Young, H.A. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut, 2015, 64, 332-341.
Horai, R.; Zárate-Bladés, C.R.; Dillenburg-Pilla, P.; Chen, J.; Kielczewski, J.L.; Silver, P.B.; Jittayasothorn, Y.; Chan, C.C.; Yamane, H.; Honda, K.; Caspi, R.R. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity, 2015, 43, 343-353.
Hube, B. Fungal adaptation to the host environment. Curr. Opin. Microbiol., 2009, 12, 347-349.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [90 - 94]
Pages: 5
DOI: 10.2174/1871530318666180817143536
Price: $65

Article Metrics

PDF: 24